WASHINGTON (AP) — For decades, patients seeking medication for pain have had two choices: over-the-counter drugs like aspirin or powerful prescription opioids like oxycodone.
Opioid prescriptions have plummeted over the last decade as doctors have become more attuned to the risks of addiction and misuse during the country’s ongoing drug epidemic.
Vertex Pharmaceuticals recently reported positive results for a non-opioid painkiller, one of several medications the Boston-based drugmaker has been developing for various forms of pain. Patients taking the drug after surgery experienced more pain relief than those getting a placebo, although the drug didn’t meet a secondary goal of outperforming treatment with an opioid.
The Associated Press spoke with Vertex’s chief scientist Dr. David Altshuler about the company’s research and development plans. The interview has been edited for length and clarity.
Bichette has 4 hits, Berríos snaps 4
Duane Eddy, legendary 'twangy' guitarist famous for Peter Gunn theme and Rebel Rouser, dies at 86
Microsoft will invest $2.2 billion in cloud, AI services in Malaysia
Zhejiang crush Shanghai to reach CBA semis
My fiancé died on the morning of our wedding day
Vegas retaliation on Stars forward Seguin costly as defending champion Knights now trail series
Faceless people, invisible hands: New Army video aims to lure recruits for psychological operations
Analysis: Larson enters conversation with Verstappen as best drivers in the world
This Texas veterinarian helped crack the mystery of bird flu in cows